| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2012-04-03 14:10:30 UTC |
|---|
| Update Date | 2025-05-29 18:10:25 UTC |
|---|
| HMDB ID | HMDB0013678 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | p-Hydroxyhippuric acid |
|---|
| Description | 4-Hydroxyhippuric acid, also known as 4-hydroxybenzoylglycine or 4-hydroxyhippate, belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. 4-Hydroxyhippuric acid is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on 4-Hydroxyhippuric acid. |
|---|
| Structure | OC(=O)CNC(=O)C1=CC=C(O)C=C1 InChI=1S/C9H9NO4/c11-7-3-1-6(2-4-7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Hydroxybenzoylglycine | ChEBI | | 4-Hydroxyhippate | Generator | | 4-Hydroxyhippic acid | Generator | | 2-[(4-Hydroxyphenyl)carbonylamino]acetic acid | HMDB | | 2-[(4-Hydroxyphenyl)formamido]acetic acid | HMDB | | 4-Hydroxyhippurate | HMDB | | 4-OH-Hippuric acid | HMDB | | p-Hydroxy-hippuric acid | HMDB | | [(4-Hydroxybenzoyl)amino]acetic acid | HMDB | | p-Hydroxyhippuric acid | HMDB | | p-Hydroxyhippate | HMDB | | p-Hydroxyhippic acid | HMDB | | 4'-Hydroxyhippurate | HMDB | | 4'-Hydroxyhippuric acid | HMDB | | 4’-hydroxyhippurate | HMDB | | 4’-hydroxyhippuric acid | HMDB | | N-(p-Hydroxybenzoyl)glycine | HMDB | | p-Hydroxyhippurate | HMDB | | 4-Hydroxyhippuric acid | ChEBI | | 2-[(4-Hydroxybenzoyl)amino]acetic acid | HMDB | | 4'-Hydroxhippuric acid | HMDB |
|
|---|
| Chemical Formula | C9H9NO4 |
|---|
| Average Molecular Weight | 195.1721 |
|---|
| Monoisotopic Molecular Weight | 195.053157781 |
|---|
| IUPAC Name | 2-[(4-hydroxyphenyl)formamido]acetic acid |
|---|
| Traditional Name | [(4-hydroxyphenyl)formamido]acetic acid |
|---|
| CAS Registry Number | 2482-25-9 |
|---|
| SMILES | OC(=O)CNC(=O)C1=CC=C(O)C=C1 |
|---|
| InChI Identifier | InChI=1S/C9H9NO4/c11-7-3-1-6(2-4-7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13) |
|---|
| InChI Key | ZMHLUFWWWPBTIU-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hippuric acids. Hippuric acids are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | Hippuric acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Hippuric acid
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid or derivatives
- Benzoyl
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxygen compound
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.6 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.6124 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.03 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 163.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 935.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 267.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 82.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 64.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 260.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 301.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 421.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 609.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 237.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 917.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 202.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 225.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 554.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 263.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 243.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-Hydroxyhippuric acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CNC(=O)C1=CC=C(O)C=C1 | 2145.7 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,1TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(C(=O)NCC(=O)O)C=C1 | 2149.8 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,1TMS,isomer #3 | C[Si](C)(C)N(CC(=O)O)C(=O)C1=CC=C(O)C=C1 | 2108.3 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CNC(=O)C1=CC=C(O[Si](C)(C)C)C=C1 | 2258.9 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O)C=C1)[Si](C)(C)C | 2153.3 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,2TMS,isomer #3 | C[Si](C)(C)OC1=CC=C(C(=O)N(CC(=O)O)[Si](C)(C)C)C=C1 | 2140.2 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O[Si](C)(C)C)C=C1)[Si](C)(C)C | 2147.5 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O[Si](C)(C)C)C=C1)[Si](C)(C)C | 2106.7 | Standard non polar | 33892256 | | 4-Hydroxyhippuric acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O[Si](C)(C)C)C=C1)[Si](C)(C)C | 2233.8 | Standard polar | 33892256 | | 4-Hydroxyhippuric acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CNC(=O)C1=CC=C(O)C=C1 | 2390.8 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(=O)NCC(=O)O)C=C1 | 2427.6 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(CC(=O)O)C(=O)C1=CC=C(O)C=C1 | 2385.1 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CNC(=O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1 | 2778.8 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O)C=C1)[Si](C)(C)C(C)(C)C | 2653.3 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C)C=C1 | 2687.1 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 2885.4 | Semi standard non polar | 33892256 | | 4-Hydroxyhippuric acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 2739.4 | Standard non polar | 33892256 | | 4-Hydroxyhippuric acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 2595.3 | Standard polar | 33892256 |
|
|---|
| Disease References | | Uremia |
|---|
- Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
| | Colorectal cancer |
|---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| | Eosinophilic esophagitis |
|---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
|---|
| General References | - Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J: SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012 Nov;404(8):2349-61. doi: 10.1007/s00216-012-6339-2. Epub 2012 Aug 31. [PubMed:22932811 ]
- van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Dore J, Westerhuis JA, Van de Wiele T: Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4531-8. doi: 10.1073/pnas.1000098107. Epub 2010 Jun 25. [PubMed:20615997 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|